000 01342 a2200373 4500
005 20250514061310.0
264 0 _c20030410
008 200304s 0 0 eng d
022 _a0167-6296
024 7 _a10.1016/S0167-6296(02)00126-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDiMasi, Joseph A
245 0 0 _aThe price of innovation: new estimates of drug development costs.
_h[electronic resource]
260 _bJournal of health economics
_cMar 2003
300 _a151-85 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCapital Expenditures
_xstatistics & numerical data
650 0 4 _aCosts and Cost Analysis
650 0 4 _aData Collection
650 0 4 _aDrug Approval
_xeconomics
650 0 4 _aDrug Evaluation
_xeconomics
650 0 4 _aDrug Evaluation, Preclinical
_xeconomics
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aDrugs, Investigational
_xeconomics
650 0 4 _aHumans
650 0 4 _aInflation, Economic
650 0 4 _aOrganizational Innovation
650 0 4 _aResearch Support as Topic
_xeconomics
650 0 4 _aUnited States
700 1 _aHansen, Ronald W
700 1 _aGrabowski, Henry G
773 0 _tJournal of health economics
_gvol. 22
_gno. 2
_gp. 151-85
856 4 0 _uhttps://doi.org/10.1016/S0167-6296(02)00126-1
_zAvailable from publisher's website
999 _c12402405
_d12402405